Epidemiology and disease burden of ulcerative colitis in Taiwan: A nationwide population-based study

Value in Health Regional Issues

Volumn 2, Issue 1, 2013, Pages 127-134

  Chen, Chung Yu ^a   Lee, Kun Tai ^b   Charles Tzu Chi, Lee ^a   Lai, Wen Ter ^b   Huang, Yaw Bin ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Disease burden; Epidemiology; Medical expenditures; Ulcerative colitis

Indexed keywords

MESALAZINE;

ADULT; AGED; ANEMIA; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DRUG COST; DRUG USE; FEMALE; HEALTH CARE COST; HEALTH SURVEY; HOSPITAL PATIENT; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTPATIENT; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; TAIWAN; TREND STUDY; ULCERATIVE COLITIS;

EID: 84877104382     PISSN: 22121099     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vhri.2013.02.006     Document Type: Article

References (49)

1. Lok K.H., Hung H.G., Ng C.H., et al. Epidemiology and clinical characteristics of ulcerative colitis in Chinese population: experience from a single center in Hong Kong. J Gastroenterol Hepatol 2008, 23:406-410.
2. Thia K.T., Loftus E.V., Sandborn W.J., Yang S.K. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol 2008, 103:3167-3182.
3. Asakura K., Nishiwaki Y., Inoue N., et al. Prevalence of ulcerative colitis and Crohn's disease in Japan. J Gastroenterol 2009, 44:659-665.
4. Morita N., Toki S., Hirohashi T., et al. Incidence and prevalence of inflammatory bowel disease in Japan: nationwide epidemiological survey during the year 1991. J Gastroenterol 1995, 30(Suppl. 8):1-4.
5. Yang S.K., Yun S., Kim J.H., et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis 2008, 14:542-549.
6. Hou J.K., El-Serag H., Thirumurthi S. Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review. Am J Gastroenterol 2009, 104:2100-2109.
7. Ooi C.J., Fock K.M., Makharia G.K., et al. The Asia-Pacific consensus on ulcerative colitis. J Gastroenterol Hepatol 2010, 25:453-468.
8. Goh K., Xiao S.D. Inflammatory bowel disease: a survey of the epidemiology in Asia. J Dig Dis 2009, 10:1-6.
9. Mahid S.S., Minor K.S., Soto R.E., et al. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 2006, 81:1462-1471.
10. Jones D.T., Osterman M.T., Bewtra M., Lewis J.D. Passive smoking and inflammatory bowel disease: a meta-analysis. Am J Gastroenterol 2008, 103:2382-2393.
11. Lakatos P.L. Environmental factors affecting inflammatory bowel disease: have we made progress?. Dig Dis 2009, 27:215-225.
12. Machida H., Tsukamoto K., Wen C.Y., et al. Association of polymorphic alleles of CTLA4 with inflammatory bowel disease in the Japanese. World J Gastroenterol 2005, 11:4188-4193.
13. *1502 confers susceptibility to ulcerative colitis, but is negatively associated with its intractability: a Korean study. Int J Colorectal Dis 2002, 17:233-237.
14. Gulwani-Akolkar B., Akolkar P.N., Lin X.Y., et al. HLA class II alleles associated with susceptibility and resistance to Crohn's disease in the Jewish population. Inflamm Bowel Dis 2000, 6:71-76.
15. Yoshitake S., Kimura A., Okada M., et al. HLA class II alleles in Japanese patients with inflammatory bowel disease. Tissue Antigens 1999, 53(4, Pt 1):350-358.
16. Shen X.Y., Shi R.H., Wang Y., et al. Toll-like receptor gene polymorphisms and susceptibility to inflammatory bowel disease in Chinese Han and Caucasian populations. Zhonghua Yi Xue Za Zhi 2010, 90:1416-1420.
17. Flasar M.H., Cross R.K., Doman D.B. Current and future role of serogenomics in ulcerative colitis. Gastroenterol Hepatol (N Y) 2011, 7:720-727.
18. Yoshida Y., Murata Y. Inflammatory bowel disease in Japan: studies of epidemiology and etiopathogenesis. Med Clin North Am 1990, 74:67-90.
19. Yang S.K., Hong W.S., Min Y.I., et al. Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong District, Seoul, Korea, 1986-1997. J Gastroenterol Hepatol 2000, 15:1037-1042.
20. Wei S.C., Shieh M.J., Chang M.C., et al. Long-term follow-up of ulcerative colitis in Taiwan. J Chin Med Assoc 2012, 75:151-155.
21. Lin H.C., Chiu C.C., Chen S.F., et al. Ulcerative colitis and pregnancy outcomes in an Asian population. Am J Gastroenterol 2010, 105:387-394.
22. Tsai C.H., Chen H.L., Ni Y.H., et al. Characteristics and trends in incidence of inflammatory bowel disease in Taiwanese children. J Formos Med Assoc 2004, 103:685-691.
23. Chang L.M., Ho K.S., Chen G.H. Ulcerative colitis in Taichung Veterans General Hospital: a clinical study. Gaoxiong Yi Xue Ke Xue Za Zhi 1995, 11:641-649.
24. Sonnenberg A. Time trends of mortality from Crohn's disease and ulcerative colitis. Int J Epidemiol 2007, 36:890-899.
25. Ouyang Q., Tandon R., Goh K.L., et al. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol 2005, 21:408-413.
26. Jiang X.L., Cui H.F. An analysis of 10218 ulcerative colitis cases in China. World J Gastroenterol 2002, 8:158-161.
27. Langan R.C., Gotsch P.B., Krafczyk M.A., Skillinge D.D. Ulcerative colitis: diagnosis and treatment. Am Fam Phys 2007, 76:1323-1330.
28. Kornbluth A., Sachar D.B. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2004, 99:1371-1385.
29. Gisbert J.P., Gomollon F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol 2008, 103:1299-1307.
30. Danovitch S.H. Fulminant colitis and toxic megacolon. Gastroenterol Clin North Am 1989, 18:73-82.
31. Bernstein C.N., Wajda A., Blanchard J.F. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clin Gastroenterol Hepatol 2008, 6:41-45.
32. Bernstein C.N., Blanchard J.F., Rawsthorne P., Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 2001, 96:1116-1122.
33. Palm O., Moum B., Jahnsen J., Gran J.T. The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study). Rheumatology (Oxford) 2001, 40:1256-1261.
34. Irvine E.J. Quality of life of patients with ulcerative colitis: past, present, and future. Inflamm Bowel Dis 2008, 14:554-565.
35. Longobardi T., Jacobs P., Wu L., Bernstein C.N. Work losses related to inflammatory bowel disease in Canada: results from a National Population Health Survey. Am J Gastroenterol 2003, 98:844-849.
36. Longobardi T., Bernstein C.N. Utilization of health-care resources by patients with IBD in Manitoba: a profile of time since diagnosis. Am J Gastroenterol 2007, 102:1683-1691.
37. Kappelman M.D., Rifas-Shiman S.L., Porter C.Q., et al. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology 2008, 135:1907-1913.
38. Baumgart D.C., Carding S.R. Inflammatory bowel disease: cause and immunobiology. Lancet 2007, 369:1627-1640.
39. Leong R.W., Lau J.Y., Sung J.J. The epidemiology and phenotype of Crohn's disease in the Chinese population. Inflamm Bowel Dis 2004, 10:646-651.
40. Chow D.K., Leong R.W., Tsoi K.K., et al. Long-term follow-up of ulcerative colitis in the Chinese population. Am J Gastroenterol 2009, 104:647-654.
41. Lee Y.M., Fock K., See S.J., et al. Racial differences in the prevalence of ulcerative colitis and Crohn's disease in Singapore. J Gastroenterol Hepatol 2000, 15:622-625.
42. Abdul-Baki H., ElHajj I., El-Zahabi L.M., et al. Clinical epidemiology of inflammatory bowel disease in Lebanon. Inflamm Bowel Dis 2007, 13:475-480.
43. Al-Shamali M.A., Kalaoui M., Patty I., et al. Ulcerative colitis in Kuwait: a review of 90 cases. Digestion 2003, 67:218-224.
44. Niv Y., Abuksis G., Fraser G.M. Epidemiology of ulcerative colitis in Israel: a survey of Israeli kibbutz settlements. Am J Gastroenterol 2000, 95:693-698.
45. Sood A., Midha V., Sood N., et al. Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut 2003, 52:1587-1590.
46. Niriella M.A., De Silva A.P., Dayaratne A.H., et al. Prevalence of inflammatory bowel disease in two districts of Sri Lanka: a hospital based survey. BMC Gastroenterol 2010, 10:32.
47. Kim B.J., Yang S.K., Kim J.S., et al. Trends of ulcerative colitis-associated colorectal cancer in Korea: a KASID study. J Gastroenterol Hepatol 2009, 24:667-671.
48. Eaden J., Abrams K., Ekbom A., et al. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther 2000, 14:145-153.
49. Yorulmaz E., Adali G., Yorulmaz H., et al. Metabolic syndrome frequency in inflammatory bowel diseases. Saudi J Gastroenterol 2011, 17:376-382.